Bristol-Myers Squibb Company (ETR:BRM)
37.90
-0.92 (-2.36%)
Oct 10, 2025, 5:35 PM CET
ETR:BRM Revenue
Bristol-Myers Squibb Company had revenue of $12.27B USD in the quarter ending June 30, 2025, with 0.56% growth. This brings the company's revenue in the last twelve months to $47.70B, up 2.57% year-over-year. In the year 2024, Bristol-Myers Squibb Company had annual revenue of $48.30B with 7.32% growth.
Revenue (ttm)
$47.70B
Revenue Growth
+2.57%
P/S Ratio
1.90
Revenue / Employee
$1.40M
Employees
34,100
Market Cap
76.98B EUR
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 48.30B | 3.29B | 7.32% |
Dec 31, 2023 | 45.01B | -1.15B | -2.50% |
Dec 31, 2022 | 46.16B | -226.00M | -0.49% |
Dec 31, 2021 | 46.39B | 3.87B | 9.09% |
Dec 31, 2020 | 42.52B | 16.37B | 62.62% |
Dec 31, 2019 | 26.15B | 3.58B | 15.89% |
Dec 31, 2018 | 22.56B | 1.79B | 8.59% |
Dec 31, 2017 | 20.78B | 1.35B | 6.94% |
Dec 31, 2016 | 19.43B | 2.87B | 17.31% |
Dec 31, 2015 | 16.56B | 681.00M | 4.29% |
Dec 31, 2014 | 15.88B | -506.00M | -3.09% |
Dec 31, 2013 | 16.39B | -1.24B | -7.01% |
Dec 31, 2012 | 17.62B | -3.62B | -17.05% |
Dec 31, 2011 | 21.24B | 1.76B | 9.03% |
Dec 31, 2010 | 19.48B | 676.00M | 3.59% |
Dec 31, 2009 | 18.81B | 1.09B | 6.17% |
Dec 31, 2008 | 17.72B | 2.10B | 13.43% |
Dec 31, 2007 | 15.62B | -591.00M | -3.65% |
Dec 31, 2006 | 16.21B | -2.40B | -12.88% |
Dec 31, 2005 | 18.61B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Siemens Healthineers AG | 23.38B |
Merck KGaA | 21.22B |
Bayer Aktiengesellschaft | 46.17B |
Fresenius SE & Co. KGaA | 22.28B |
Fresenius Medical Care AG | 19.52B |
Sartorius Aktiengesellschaft | 3.47B |
Fielmann Group AG | 2.40B |
Carl Zeiss Meditec AG | 2.18B |
Bristol-Myers Squibb Company News
- 13 hours ago - Bristol Myers Squibb: Value Emerges From Distress - Seeking Alpha
- 1 day ago - Bristol Myers Squibb Buys Private Biotech for $1.5 Billion. The Deal Wave Keeps Going. - Barron's
- 1 day ago - Bristol-Myers Squibb (BMY) Expands Cell Therapy Portfolio with $1.5 Billion Acquisition - GuruFocus
- 1 day ago - Bristol Myers Squibb (BMY) Expands with Orbital Therapeutics Acquisition - GuruFocus
- 1 day ago - Bristol Myers (BMY) to Acquire Orbital Therapeutics in $1.5 Billion Deal - GuruFocus
- 1 day ago - Bristol-Myers buys Orbital Therapeutics for $1.5 billion - CNBC
- 1 day ago - Bristol Myers Squibb to buy Orbital Therapeutics for $1.5B in cash - Seeking Alpha
- 1 day ago - Bristol Myers Squibb and National Community Pharmacists Association Pilot Rural Heart Health Care Initiatives - Wallstreet:Online